REFERENCES
- Leung A, Weisbrod D, Schwartz C. Intravitreal ranibizumab in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy. Can J Ophthalmol 2010; 45:3:300–301.
- Chan WM, Lai TY, Liu DT, Lam DS. Intravitreal bevacizumab (Avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 2007;143:977–83.
- Vossmerbaeumer U, Spandau UH, Baltz S, Wickenhaeuser A, Jonas JB. Intravitreal bevacizumab for choroidal neovascularisation secondary to punctate inner choroidopathy. Clin Experiment Ophthalmol. 2008 Apr; 36(3):292–4.